HilleVax

is a Massachusetts-based biopharmaceutical company that researches and develops novel vaccines for the treatment of acute gastroenteritis disorders...
Read more
HilleVax Chairman & CEO: Rob Hershberg

Chairman & CEO

Rob Hershberg

CEO Approval Rating

90/100

Annual Revenue
<$1M
Employees
20
Funding
$450M

HilleVax Competitors

1Moderna
2Takeda Pharmaceutical
3Sanofi
4Merck
5CSL Behring
6Vaxart
7Medicago
8Bharat Biotech
9GSK
10Pfizer

Trending Companies